AS

Ayyangalam Sasikala

Active Director Managing Director DIN 11320192
DIN 11320192 First appointment Oct 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ayyangalam Sasikala

Data last updated:

Ayyangalam Sasikala is a Managing Director at Clivoralife Science Private Limited (since 2025). The company operates in Biotechnology.

DIN 11320192
Primary Designation Managing Director
Industry Biotechnology
First Appointment 16 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clivoralife Science Private Limited U72200KA2025PTC209828
Managing Director16 Oct 20252025Active

Board colleagues of Ayyangalam Sasikala

NameDINCompanyDesignation
Bindu Balakrishna11320254Clivoralife Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clivoralife Science Private Limited
Premium access

Shareholding and investment profile for Ayyangalam Sasikala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayyangalam Sasikala

Ayyangalam Sasikala currently holds 1 directorship: Clivoralife Science Private Limited (Managing Director, since 16 Oct 2025).

Ayyangalam Sasikala was first appointed on 16 Oct 2025 as Managing Director at Clivoralife Science Private Limited.

The current boards of Ayyangalam Sasikala's companies include Bindu Balakrishna (Clivoralife Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available